6887 Stock Chart & Stats
HK$46.78
--
Market closed
HK$46.78
--
Day’s Range― - ―
52-Week RangeHK$15.01 - HK$56.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)360.45K
Market Cap
HK$22.05B
Enterprise ValueHK$26.82K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)63.3
Beta1.03
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.70
Shares Outstanding321,103,150
10 Day Avg. Volume311,866
30 Day Avg. Volume360,447
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Sunshine Lake Pharma Co., Ltd. Class H News
6887 FAQ
What was Sunshine Lake Pharma Co., Ltd. Class H’s price range in the past 12 months?
Sunshine Lake Pharma Co., Ltd. Class H lowest stock price was HK$15.01 and its highest was HK$56.00 in the past 12 months.
What is Sunshine Lake Pharma Co., Ltd. Class H’s market cap?
Sunshine Lake Pharma Co., Ltd. Class H’s market cap is HK$22.05B.
When is Sunshine Lake Pharma Co., Ltd. Class H’s upcoming earnings report date?
Sunshine Lake Pharma Co., Ltd. Class H’s upcoming earnings report date is Aug 31, 2026 which is in 3 days.
How were Sunshine Lake Pharma Co., Ltd. Class H’s earnings last quarter?
Sunshine Lake Pharma Co., Ltd. Class H released its earnings results on Mar 31, 2026. The company reported HK$0.699 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Sunshine Lake Pharma Co., Ltd. Class H overvalued?
According to Wall Street analysts Sunshine Lake Pharma Co., Ltd. Class H’s price is currently Overvalued.
Does Sunshine Lake Pharma Co., Ltd. Class H pay dividends?
Sunshine Lake Pharma Co., Ltd. Class H does not currently pay dividends.
What is Sunshine Lake Pharma Co., Ltd. Class H’s EPS estimate?
Sunshine Lake Pharma Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sunshine Lake Pharma Co., Ltd. Class H have?
Sunshine Lake Pharma Co., Ltd. Class H has 321,103,150 shares outstanding.
What happened to Sunshine Lake Pharma Co., Ltd. Class H’s price movement after its last earnings report?
Sunshine Lake Pharma Co., Ltd. Class H reported an EPS of HK$0.699 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.672%.
Which hedge fund is a major shareholder of Sunshine Lake Pharma Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:6887
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sunshine Lake Pharma Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
5.20%
Trailing 12-Months
Company Description
Sunshine Lake Pharma Co., Ltd. Class H
Sunshine Lake Pharma Co., Ltd. operates as a pharmaceutical company. It engages in the research, development, production and commercialization of modified new drugs, generic drugs and biosimilars. The company was founded on December 29, 2003 and is headquartered in Dongguan, China.
Technical Analysis
Extrawell Pharmaceutical Holdings Limited
―
Tianda Pharmaceuticals Ltd.
―
Lee's Pharmaceutical Holdings Limited
―
Fusen Pharmaceutical Co., Ltd.
―
Sinco Pharmaceuticals Holdings Ltd.
―